Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2019

MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Names Senior Advisor to Outline Leadership Strategies

Posted on December 6, 2019 by MissionIR

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator with technology that has demonstrated its ability to enhance the oral delivery of nicotine, recently appointed Gregg Smith, founder of a New York-based culture-tech, venture investment firm, as senior advisor to … Continue reading →

Posted in Lexaria Bioscience Corp. (LXRP), MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Enters Non-Binding LOI to Acquire Controlling Equity Interest in Fuzhou Csfctech Co., Ltd.

Posted on December 6, 2019 by MissionIR

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced its entry into a non-binding letter of intent (“LOI”) to acquire a controlling … Continue reading →

Posted in Blue Hat Interactive Entertainment Technology BHAT, MissionIRNewsBreaks | Leave a comment

Predictive Oncology Inc.’s (NASDAQ: POAI) TumorGenesis Tech Primed to Play Key Role in Cancer Drug Development Efforts

Posted on December 5, 2019 by MissionIR

Predictive Oncology subsidiary TumorGenesis developing faster, less costly, and more accurate PDx cancer models that better mimic the patient’s tumor TumorGenesis revolutionary technology will provide pharmaceuticals with quicker and more effective drug development while significantly improving patient outcomes There’s an … Continue reading →

Posted in Predictive Oncology Inc. POAI | Leave a comment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Makes Edible Drug Delivery Platform Even Faster

Posted on December 5, 2019 by MissionIR

Lexaria Bioscience is a company that is passionate about establishing alternatives to inhalation for rapid-response drug substance delivery in order to eliminate the lung harm that smoking or vaping may cause Lexaria’s DehydraTECH platform has generated numerous patents with more … Continue reading →

Posted in Lexaria Bioscience Corp. (LXRP) | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Multiple Indications of Interest for Skyline Medical Division

Posted on December 5, 2019 by MissionIR

Predictive Oncology (NASDAQ: POAI), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its receipt of interest from several parties for the possible acquisition of its Skyline Medical division, which produces and sells the STREAMWAY … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Platform Revolutionizing Cancer Treatment

Posted on December 4, 2019 by MissionIR

Predictive Oncology (NASDAQ: POAI) is a knowledge-driven, precision-medicine company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery. An article discussing the company reads, “POAI’s platform, composed of over 150,000 patient tumors, harnesses the power of an … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Drug Delivery Platform Proven to Enhance Absorption of Bioactive Compounds

Posted on December 4, 2019 by MissionIR

DehydraTECH™ is patent protected for multiple Active Pharmaceutical Ingredients (APIs) including hemp oil CBD and cannabis, nicotine, non-steroidal anti-inflammatory drugs, and fat-soluble vitamins Lexaria has 16 patents granted and over 60 patent applications pending worldwide DehydraTECH™ shown to facilitate rapid … Continue reading →

Posted in Lexaria Bioscience Corp. (LXRP) | Leave a comment

MissionIRNewsBreaks – GP Solutions, Inc. (GWPD) Featured in Article Discussing Controlled Environment Micro-Farms as Partial Solution Amidst Recent E. Coli Outbreak

Posted on December 4, 2019 by MissionIR

GP Solutions (OTC: GWPD), the developer of modular automated micro-farms, may help in solving the E.coli crisis that is sickening dozens across America according to Business Management News. Per the article, dozens of people were infected across 19 states in … Continue reading →

Posted in GP Solutions GWPD, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Announces Establishment of At-The-Market Equity Program

Posted on December 4, 2019 by MissionIR

Organigram Holdings (NASDAQ: OGI) (TSX: OGI) today announced that it has established an at-the-market equity program (“ATM Program”) that allows the corporation, at its discretion, to issue up to C$55,000,000 (or its U.S. dollar equivalent) of common shares from treasury … Continue reading →

Posted in MissionIRNewsBreaks, Organigram Holdings Inc. OGI | Leave a comment

Sigma Labs Inc. (NASDAQ: SGLB) Releases Q3 Numbers, Remains at the Forefront of Next Industrial Revolution

Posted on December 4, 2019 by MissionIR

Company reports increased revenue over last year’s Q3 numbers Key operational highlights point to even stronger revenue growth moving into 2020 Sigma Labs’ pioneering software provides essential element to spur additive manufacturing into the next industrial revolution Sigma Labs Inc. … Continue reading →

Posted in Sigma Labs Inc. SGLB | Leave a comment